Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R O Schlingemann

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|September 18, 2002
[Eye problems due to contact lenses; an advisory report from the Health Council of the Netherlands]R O Schlingemann, C P Nieuwendaal
Progress in Brain Research|August 8, 2009
Treatment of retinal diseases with VEGF antagonistsR O Schlingemann, A N Witmer
The British Journal of Ophthalmology|June 1, 1997
Role of vascular permeability factor/vascular endothelial growth factor in eye diseaseR O Schlingemann, V W van Hinsbergh
Ophthalmology|December 1, 1996
Idiopathic granulomatous orbital inflammationI Mombaerts, R O Schlingemann, R Goldschmeding, et al.
Survey of Ophthalmology|July 1, 1996
What is orbital pseudotumor?I Mombaerts, R Goldschmeding, R O Schlingemann, et al.
Ophthalmology|March 1, 1996
Are systemic corticosteroids useful in the management of orbital pseudotumors?I Mombaerts, R O Schlingemann, R Goldschmeding, et al.
The Journal of Pathology|December 25, 2003
Are tumours angiogenesis-dependent?H M W Verheul, E E Voest, R O Schlingemann
American Journal of Ophthalmology|December 1, 1996
Twenty years' delay of fellow eye involvement in herpes simplex virus type 2-associated bilateral acute retinal necrosis syndromeR O Schlingemann, M Bruinenberg, P Wertheim-van Dillen, et al.
The British Journal of Ophthalmology|June 1, 2005
Spare the rod and spoil the eyeG B Arden, R L Sidman, W Arap, et al.
Lancet (London, England)|February 17, 1996
Amaurosis fugax on standing and angle-closure glaucoma with clomipramineR O Schlingemann, A A Smit, H F Lunel, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Nederlands Tijdschrift Voor Geneeskunde|September 18, 2002
[Eye problems due to contact lenses; an advisory report from the Health Council of the Netherlands]R O Schlingemann, C P Nieuwendaal
Progress in Brain Research|August 8, 2009
Treatment of retinal diseases with VEGF antagonistsR O Schlingemann, A N Witmer
The British Journal of Ophthalmology|June 1, 1997
Role of vascular permeability factor/vascular endothelial growth factor in eye diseaseR O Schlingemann, V W van Hinsbergh
Ophthalmology|December 1, 1996
Idiopathic granulomatous orbital inflammationI Mombaerts, R O Schlingemann, R Goldschmeding, et al.
Survey of Ophthalmology|July 1, 1996
What is orbital pseudotumor?I Mombaerts, R Goldschmeding, R O Schlingemann, et al.
Ophthalmology|March 1, 1996
Are systemic corticosteroids useful in the management of orbital pseudotumors?I Mombaerts, R O Schlingemann, R Goldschmeding, et al.
The Journal of Pathology|December 25, 2003
Are tumours angiogenesis-dependent?H M W Verheul, E E Voest, R O Schlingemann
American Journal of Ophthalmology|December 1, 1996
Twenty years' delay of fellow eye involvement in herpes simplex virus type 2-associated bilateral acute retinal necrosis syndromeR O Schlingemann, M Bruinenberg, P Wertheim-van Dillen, et al.
The British Journal of Ophthalmology|June 1, 2005
Spare the rod and spoil the eyeG B Arden, R L Sidman, W Arap, et al.
Lancet (London, England)|February 17, 1996
Amaurosis fugax on standing and angle-closure glaucoma with clomipramineR O Schlingemann, A A Smit, H F Lunel, et al.
Pageof 6